The Annual Congress of International Drug Discovery Science & Technology (IDDST), initiated from 2003, has attracted more than 10,000 participants from over 50 countries and regions in the previous 20 years.
The 21st IDDST (Europe), June 18 – 20, 2025 in Stockholm, will host leading scientists from the academia and outstanding international experts from industry worldwide, to discuss the latest developments in drug discovery and therapy. The program will offer complete updates of recent developments and present the latest results in the remarkable separate tracks. Main idea and target is to stimulate new creative ideas to translate new discoveries into better practice and application.
In session 504 Cardiovascular Diseases Drug R&D Pipelines our collaboration partner, Prof. Dr. Guy Salama from Pittsburgh Medical University, will be giving a talk about the latest relaxin-2 results in heart failure with preserved ejection fraction (HFpEF), titled “Daily injections of Relaxin 2, its pharmacokinetics and remodeling of rat hearts with Heart Failure with preserved Ejection Fraction”.
The CEO and chairman of Relaxera, Prof. Dr. Thomas Bernd Dschietzig will give a keynote presentation on relaxin-2: “Human relaxin-2 – a natural hormone holds promise to tackle the HFpEF pandemic”.
Information about the conference and the program is available online.
Venue: Clarion Hotel Stockholm, Sweden
Address: Ringvägen 98, 104 60, Stockholm, Sweden